`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Park, Sam <SPark@winston.com>
`Friday, September 29, 2017 12:19 PM
`Trials
`Parmelee, Steve; jmills@wsgr.com; mrosato@wsgr.com; jlove@gibsondunn.com; ahollis@kirkland.com;
`egoryunov@kirkland.com; greg.springsted@kirkland.com; RTrenchard@gibsondunn.com
`RE: IPR2017-01929 motion for joinder
`
`Your Honors,
`
`I am the lead counsel for Petitioners Sun Pharmaceutical Industries, Ltd., Sun Pharmaceutical Industries, Inc., and Sun Pharma Global FZE (“Sun”) in
`IPR2017‐01929.
`
` write to inform the Board that counsel for joined petitioners Actavis Elizabeth LLC and Teva Pharmaceuticals USA, Inc. (collectively “Actavis”),
`independently, has informed Sun that Actavis does not oppose Sun’s motion to join IPR2017‐00854. Sun agrees to the same conditions as set forth
`in Paper 23 of IPR2017‐00854.
`
`Please let me know if you need any additional information. I have copied counsel for Patent Owner, Apotex, and Actavis to this correspondence.
`
`
`Respectfully submitted,
`Sam Park (Reg. No. 59,656)
`Lead Counsel for Sun
`
`
` I
`
`Samuel S. Park
`Partner
`Winston & Strawn LLP
`35 W. Wacker Drive
`Chicago, IL 60601-9703
`D: +1 312-558-7931
`F: +1 312-558-5700
`Bio | VCard | Email | winston.com
`Admitted to practice in Illinois, New York, U.S. Patent & Trademark Office
`
`
`
`1
`
`
`
`Please consider the environment before printing this e-mail.
`
`From: Trials [mailto:Trials@USPTO.GOV]
`Sent: Wednesday, September 27, 2017 12:38 PM
`To: Park, Sam <SPark@winston.com>; jlove@gibsondunn.com
`Cc: Trials <Trials@USPTO.GOV>; Parmelee, Steve <sparmelee@wsgr.com>
`Subject: IPR2017‐01929 motion for joinder
`
`Counsel,
`
`On September 26, 2017, a representative of Petitioner Sun Pharma called to inquire about the status of their motion for joinder with IPR2017-00854, filed August
`16, 2017. Paper 3. The time for Patent Owner to oppose the motion under 37 C.F.R. § 42.25(a)(1) has expired. Sun Pharma indicates that lead Petitioner of
`IPR2017-00854, Apotex, does not oppose the motion. Id. at 2; see also, id. at n.1 (indicating that joined Petitioner Argentum also does not oppose).
`
`On September 9, 2017, we issued an Order further joining Actavis Elizabeth LLC and Teva Pharmaceuticals USA, Inc. (collectively “Actavis”) to this
`proceeding. See IPR2017-00854, Paper 23. To expedite our consideration of its motion, Sun Pharma should indicate if lead Petitioner Apotex speaks for Actavis,
`or if Actavis, independently, does not oppose the motion and agrees to the same conditions as set forth in Paper 23 of IPR2017-00854.
`
`Regards,
`
`Andrew Kellogg,
`Supervisory Paralegal
`Patent Trial and Appeal Board
`USPTO
`andrew.kellogg@uspto.gov
`Direct: 571-272-5366
`
`
`
`
`
`The contents of this message may be privileged and confidential. If this message has been received in error, please delete it without reading it. Your receipt of this message is not intended to waive any applicable
`privilege. Please do not disseminate this message without the permission of the author. Any tax advice contained in this email was not intended to be used, and cannot be used, by you (or any other taxpayer) to avoid
`penalties under applicable tax laws and regulations.
`
`2
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
